AUTM Technology Valuation Course Agenda

AbbvieLilly
AUTM Annual Meeting

AUTM Technology Valuation Course Agenda

Sunday, March 8
7:30 a.m. – 4 p.m.
View Faculty  
 

Sunday, March 8

7:30 a.m. Welcome and Introduction
7:30 – 7:50 a.m. Creating Value

This session focuses on creating value, providing an understanding of the licensee's business model and key success factors, the importance of the licensed intellectual property in generating value, and how these affect license terms and negotiation.

Instructor                           
Michael Sharer, Lawrence Livermore National University‚Äč
7:50 – 9:05 a.m. Measuring Value

This session centers on measuring value, examining key accounting assumptions, the measures and projections that quantify the financial performance of the licensee and how these are used to determine the commercial terms of the license.

Instructors
Steve Ferguson, National Institutes of Health
Michael Sharer, Lawrence Livermore National University
Debbie Stewart, Invotex IP

9:05 – 9:20 a.m. 

Sharing Value
This session examines the key mechanisms used to share value between the licensee and the licensor.

Instructors
Steve Ferguson, National Institutes of Health
Ashley Stevens, Focus IP Group, LLC

9:20 – 9:35 a.m. Morning Break
9:35 – 10:15 a.m. 

Sharing Value (Continued)

Instructors
Steve Ferguson, National Institutes of Health
Ashley Stevens, Focus IP Group, LLC

10:15 – 11:05 a.m. 

Start-ups
This session explores the issues specific to licensing start-ups, including taking on equity as partial consideration for the license.

Instructors
Steve Ferguson, National Institutes of Health
Ashley Stevens, Focus IP Group, LLC

11:05 – 11:45 a.m.  Case Study Discussions

Instructor
Michael Sharer, Lawrence Livermore National University
11:45 a.m. – 12:45 p.m. Lunch
12:45 – 3 p.m. Case Study Discussions (Continued)
3 – 3:15 p.m. Afternoon Break
3:15 – 3:50 p.m. Case Study Discussions (continued)
3:50 – 4 p.m. Wrap-up Discussions and Questions
4 p.m.     Course Adjourns


Annual Meeting Sponsors

AstraZeneca
Astellas
Elanco Animal Health
Osage University Partners
PhRMA
Amster, Rothstein & Ebenstein LLP
NIIMBL
Burford Capital
Merck
Parker Highlander PLLC
Boehringer Ingelheim Pharmaceuticals Inc.
Ventech Solutions Inc.
Pfizer Inc
Marshall Gerstein
Michael Best & Friedrich
LifeArc
Polsinelli PC
CSL Behring
Bereskin & Parr LLP
Novartis Institutes for BioMedical Research
Oblon
Hamilton Brook Smith Reynolds
Eli Lilly and Company
BCC Research
AbbVie
Schwegman Lundberg & Woessner
Wilson Sonsini Goodrich & Rosati
Blank Rome LLP
Aird & McBurney LP
MPEG LA LLC
Baker Donelson
Casimir Jones, SC
Royalty Pharma
Smith, Gambrell & Russell
Pabst Patent Group LLP
CrossPond Law
University of New Hampshire
Quarles & Brady LLP
Hodgson Russ LLP
Murgitroyd
Wellspring
TreMonti Consulting LLC
Licensing Executives Society